NR1H4 and metabolic dysfunction-associated steatotic liver disease: The role of secondary BAs in the pathogenesis of MASLD is not clear since they have a paradoxical effect on the Farnesoid X Receptor (FXR), acting either as an agonist or antagonist with a distinct affinity according to their structure [21].